Viewing Study NCT01160003


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-25 @ 4:57 PM
Study NCT ID: NCT01160003
Status: COMPLETED
Last Update Posted: 2017-06-14
First Post: 2010-07-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Blinded, Dose Ascending Study to Assess the Pharmacokinetics, Safety and Tollerability of Repeat Inhaled Doses of Nebulised GW870086X in Healthy Adult Male Volunteers.
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module